home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Growth Or Death? For NMDA Receptors, It’s Location That Matters

  April, 20 2002 1:16
your information resource in human molecular genetics
Under normal circumstances, glutamate serves as a nurturing neural signal important for growth and plasticity, but in some disease states it can act as a lethal killer. A paper in the May issue of Nature Neuroscience sheds light on the molecular events that determine how and when signaling through the NMDA subtype of glutamate receptor crosses the line between life and death.

Hilmar Bading and colleagues provide evidence that a key determinant of the nature of NMDA receptor signaling is the location of the activated receptors. Growth- and survival-promoting signals derive from NMDA receptors at the synapses, the sites of communication between neurons in the brain. In contrast, a cell death–promoting signal emerges from NMDA receptors on the cell’s surface but outside of synapses. This death signal appears to attain dominance when both pathways are activated together, because it shuts off the gene regulation protein CREB that is turned on by synaptic NMDA receptors. Thus one exciting future challenge will be to develop safe and effective ways to block extrasynaptic, but not synaptic, NMDA receptors. Such tools may help prevent cell loss during stroke and perhaps also in neurodegenerative diseases like Alzheimer’s disease.

Author contact:

Dr. Hilmar Bading
Dept of Neurobiology
University of Heidelberg, Germany
Tel: +49 622 154 8218
E-mail: hilmar.bading@uni-hd.de

Additional contact for comment on paper:

Dr. David Ginty
Dept of Neuroscience
Johns Hopkins University School of Medicine
Baltimore, MD, USA
Tel: +1 410 614 9494
E-mail: dginty@jhmi.edu

Also available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.